A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients
NCT04516655
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Central Nervous System Lymphoma
Interventions
DRUG:
chidamide combined with rituximab and high-dose methotrexate
Sponsor
Fudan University